Oak Family Advisors’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-51,711
Closed -$407K 126
2024
Q3
$407K Sell
51,711
-13,214
-20% -$133K 0.13% 100
2024
Q2
$728K Buy
64,925
+1,208
+2% +$14.1K 0.25% 74
2024
Q1
$807K Buy
63,717
+202
+0.3% +$2.66K 0.31% 69
2023
Q4
$872K Buy
63,515
+17
+0% +$199 0.37% 63
2023
Q3
$717K Sell
63,498
-2,651
-4% -$31.8K 0.34% 60
2023
Q2
$884K Sell
66,149
-38,482
-37% -$451K 0.42% 54
2023
Q1
$1.21M Sell
104,631
-511
-0.5% -$6.01K 0.6% 47
2022
Q4
$1.26M Buy
105,142
+15,165
+17% +$197K 0.68% 44
2022
Q3
$1.17M Buy
+89,977
New +$1.1M 0.63% 41

Other funds holding BIOX

Oak Family Advisors's BIOX Position: Q4 2024 in Review

Oak Family Advisors sold out of Bioceres Crop Solutions (BIOX) in Q4 2024, closing a stake of 51,711 shares — an estimated $407K sold.

Oak Family Advisors first reported a position in BIOX in Q3 2022 and held it in 9 quarters. The position peaked at $1.26M in Q4 2022. 43 funds tracked by Wall St. Rank hold BIOX as of Q4 2024.

  • Oak Family Advisors reported no remaining Bioceres Crop Solutions position as of Q4 2024 after selling out during the quarter.
  • Oak Family Advisors sold 51,711 Bioceres Crop Solutions shares in Q4 2024, an estimated $407K.
  • Oak Family Advisors first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 9 quarters.
  • Oak Family Advisors's Bioceres Crop Solutions position peaked at $1.26M in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2024.

Based on Oak Family Advisors's 13F filing for Q4 2024, filed 24 Jan 2025.